How It Works
Watch Maverick™ Technology In Action
31 Patent Issued and 17 Pending
Our proprietary Maverick™ Diagnostic System (MDS) has 31 patents issued and 17 patents pending worldwide.
Improving Overall Patient Care
In order to improve overall patient care with rapid laboratory diagnostics, Genalyte became a clinical diagnostic provider receiving CLIA certification and CAP accreditation.
FDA Clearance and EUA Authorization
The Maverick™ Diagnostic System (MDS) received FDA clearance for RNP (ribonuceloprotein) assay in October 2019.
In addition, the Maverick™ Diagnostic System (MDS) received Emergency Use Authorization (EUA) by the FDA for SARS-CoV-2 Multi-Antigen Serology Panel in October 2020